DE69842245D1 - Vorbereitung von Zellen für die Herstellung von Biologika - Google Patents

Vorbereitung von Zellen für die Herstellung von Biologika

Info

Publication number
DE69842245D1
DE69842245D1 DE69842245T DE69842245T DE69842245D1 DE 69842245 D1 DE69842245 D1 DE 69842245D1 DE 69842245 T DE69842245 T DE 69842245T DE 69842245 T DE69842245 T DE 69842245T DE 69842245 D1 DE69842245 D1 DE 69842245D1
Authority
DE
Germany
Prior art keywords
cells
production
preparation
batch
biologics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69842245T
Other languages
English (en)
Inventor
Rudi Brands
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Biologicals BV
Original Assignee
Abbott Biologicals BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8229133&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69842245(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Biologicals BV filed Critical Abbott Biologicals BV
Application granted granted Critical
Publication of DE69842245D1 publication Critical patent/DE69842245D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00—Tissue, human, animal or plant cell, or virus culture apparatus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Sustainable Development (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69842245T 1997-12-24 1998-12-17 Vorbereitung von Zellen für die Herstellung von Biologika Expired - Lifetime DE69842245D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97204110 1997-12-24

Publications (1)

Publication Number Publication Date
DE69842245D1 true DE69842245D1 (de) 2011-06-09

Family

ID=8229133

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69837287T Expired - Lifetime DE69837287T3 (de) 1997-12-24 1998-12-17 Herstellung von zellen für die produktion von biologischen produkten
DE69842245T Expired - Lifetime DE69842245D1 (de) 1997-12-24 1998-12-17 Vorbereitung von Zellen für die Herstellung von Biologika

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69837287T Expired - Lifetime DE69837287T3 (de) 1997-12-24 1998-12-17 Herstellung von zellen für die produktion von biologischen produkten

Country Status (26)

Country Link
US (1) US20070148753A1 (de)
EP (2) EP1801201B1 (de)
JP (1) JP4478328B2 (de)
KR (1) KR100683429B1 (de)
CN (1) CN1185339C (de)
AT (2) ATE356197T1 (de)
AU (1) AU758209B2 (de)
BR (1) BR9814490A (de)
CA (1) CA2316739C (de)
CZ (1) CZ299719B6 (de)
DE (2) DE69837287T3 (de)
DK (2) DK1060241T4 (de)
ES (2) ES2365631T3 (de)
HK (1) HK1030628A1 (de)
HU (1) HUP0100538A3 (de)
ID (1) ID26784A (de)
IL (1) IL136736A (de)
NO (1) NO329385B1 (de)
NZ (1) NZ505371A (de)
PL (1) PL196042B1 (de)
PT (2) PT1801201E (de)
RU (1) RU2230784C2 (de)
SK (1) SK285971B6 (de)
TR (1) TR200001960T2 (de)
UA (1) UA72732C2 (de)
WO (1) WO1999033955A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2612154C2 (ru) 2009-12-23 2017-03-02 Санофи Пастер Способ культивирования адгезионных клеток
EP3737750B1 (de) 2018-01-09 2024-06-05 Theriva Biologics, Inc. Alkalische phosphatasemittel zur behandlung von entwicklungsstörungen des nervensystems
CA3094173A1 (en) 2018-03-20 2019-09-26 Synthetic Biologics, Inc. Intestinal alkaline phosphatase formulations
CA3094174A1 (en) 2018-03-20 2019-09-26 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
US20190367858A1 (en) * 2018-06-01 2019-12-05 Lonza Ltd. Midscale Model For Organic Growth and Phasing
EP4008774A4 (de) * 2019-07-16 2023-09-27 Innovent Biologics (Suzhou) Co., Ltd. Zellkulturverfahren und seine anwendung auf der basis von hochdichter und kontinuierlicher inokulation
EP4339274A1 (de) 2022-09-13 2024-03-20 Sartorius Stedim Biotech GmbH Verfahren zum betreiben einer bioprozessanlage zur herstellung eines bioprodukts

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60151458A (ja) 1984-01-20 1985-08-09 Nippon Piston Ring Co Ltd カムシヤフト
US4664912A (en) * 1984-10-01 1987-05-12 Wiktor Tadeusz J Process for the large scale production of rabies vaccine
DE3833925A1 (de) * 1988-03-11 1989-09-21 Inst Angewandte Biotechnologie Verfahren und herstellung von virus und viralem antigen und vorrichtung hierzu
US5017490A (en) 1989-03-10 1991-05-21 Baxter International Inc. Method for in vitro reproduction and growth of cells in culture medium
DE3930140A1 (de) * 1989-09-09 1991-03-21 Bayer Ag Verfahren zur herstellung von biologischen materialien in zellkulturen und vorrichtungen
WO1992010564A1 (en) * 1990-12-13 1992-06-25 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
KR100669716B1 (ko) * 2004-07-14 2007-01-16 삼성에스디아이 주식회사 페닐카르바졸 화합물 및 이를 이용한 유기 전계 발광 소자
KR100573137B1 (ko) * 2004-04-02 2006-04-24 삼성에스디아이 주식회사 플루오렌계 화합물 및 이를 이용한 유기 전계 발광 소자
US8188315B2 (en) * 2004-04-02 2012-05-29 Samsung Mobile Display Co., Ltd. Organic light emitting device and flat panel display device comprising the same
KR100787425B1 (ko) * 2004-11-29 2007-12-26 삼성에스디아이 주식회사 페닐카바졸계 화합물 및 이를 이용한 유기 전계 발광 소자
JP4184332B2 (ja) * 2004-11-22 2008-11-19 本田技研工業株式会社 可変気筒式内燃機関の制御装置

Also Published As

Publication number Publication date
DK1060241T3 (da) 2007-06-04
SK285971B6 (sk) 2007-12-06
CZ299719B6 (cs) 2008-10-29
RU2230784C2 (ru) 2004-06-20
ES2281148T3 (es) 2007-09-16
ID26784A (id) 2001-02-08
JP4478328B2 (ja) 2010-06-09
PL196042B1 (pl) 2007-11-30
HUP0100538A3 (en) 2006-01-30
PT1060241E (pt) 2007-04-30
CA2316739A1 (en) 1999-07-08
TR200001960T2 (tr) 2001-02-21
WO1999033955A1 (en) 1999-07-08
IL136736A0 (en) 2001-06-14
CN1185339C (zh) 2005-01-19
EP1060241B1 (de) 2007-03-07
KR20010033558A (ko) 2001-04-25
NO329385B1 (no) 2010-10-11
UA72732C2 (en) 2005-04-15
HUP0100538A2 (hu) 2001-06-28
ES2281148T5 (es) 2011-03-09
DK1060241T4 (da) 2011-01-24
US20070148753A1 (en) 2007-06-28
NZ505371A (en) 2001-11-30
CA2316739C (en) 2011-06-21
EP1801201A1 (de) 2007-06-27
DE69837287D1 (de) 2007-04-19
EP1801201B1 (de) 2011-04-27
ATE356197T1 (de) 2007-03-15
SK9652000A3 (en) 2000-12-11
DE69837287T3 (de) 2011-06-22
NO20003215L (no) 2000-06-21
PT1801201E (pt) 2011-07-05
CN1283223A (zh) 2001-02-07
DE69837287T2 (de) 2007-07-05
PL341401A1 (en) 2001-04-09
ES2365631T3 (es) 2011-10-07
JP2002500005A (ja) 2002-01-08
NO20003215D0 (no) 2000-06-21
EP1060241A1 (de) 2000-12-20
HK1030628A1 (en) 2001-05-11
AU758209B2 (en) 2003-03-20
KR100683429B1 (ko) 2007-02-20
BR9814490A (pt) 2000-10-10
EP1060241B2 (de) 2010-10-20
AU2417999A (en) 1999-07-19
ATE507284T1 (de) 2011-05-15
DK1801201T3 (da) 2011-07-11
IL136736A (en) 2004-06-01
CZ20002343A3 (cs) 2000-10-11

Similar Documents

Publication Publication Date Title
MX9703681A (es) Metodo para hacer una coleccion de compuestos.
EP0764719A3 (de) Methoden zur Züchtung von Tierzellen
ATE260989T1 (de) Erkenntnisse der genomforschung für die suche nach neuartigen wirkstoffen
WO2002040630A3 (en) Process of decellularizing biological matrices and acellular biological matrices useful in tissue engineering
DE60234437D1 (de) Verfahren und vektoren für die amplifikation oder expression von nucleinsäuren in pflanzen
DE69518437D1 (de) Verfahren zur herstellung transformierter zellen
WO2004053096A3 (en) Engineering three-dimensional tissue structures using differentiating embryonic stem cells
BR8200191A (pt) Celula viva renina preprorrenina prorrenina processo para obter expressao de preporrenina prorrenina e renina gene de prorrenina preprorrenina e renina e coli material dna recombinador saccharomyces cerevisiae polipetidio processo para exprimir um gene
ATE383417T1 (de) Produktion lymphoider gewebsspezifischer zellen von hämatopoietischen vorläuferzellen in einem dreidimensionalen system
DE69939947D1 (de) Verfahren zur herstellung von polypeptiden in mutierten aspergillus zellen
ATE209679T1 (de) Proteine mit faktor viii aktivität, verfahren zu deren herstellung unter verwendung von genetisch modifizierten zellen und diese enthaltende zusammensetzungen
EP0474790A4 (en) Media for cell growth and method for making them
DE69426692T2 (de) Methode zur herstellung von taxan-diterpen und methode zum einten von kulturzellen, die taxan-diterpen in hohen ausbeuten herstellen
DE69842245D1 (de) Vorbereitung von Zellen für die Herstellung von Biologika
EP1200557A4 (de) Verfahren zur herstellung künstlicher pflanzenchromosomen
FR2709496B1 (fr) Procédé de production de plantes transgéniques, entièrement transformées en génération T0, à partir de méristèmes.
IE45274L (en) Process for culturing cells.
EP0378921A3 (de) Erhöhung der Produktion von Pflanzenmetaboliten durch zeitlich reguliertes Herausholen
DE68929296T2 (de) Verfahren zur biochemischen Oxidation von Steroiden sowie dafür verwendbare, genetisch manipulierte Zellen
DE69939876D1 (de) Methoden zur massenkultivierung von zellen die rekombinantes menschliches erythropoietin produzieren
DE60140526D1 (de) Herstellung von tcr gamma delta t-zellen
ATE297981T1 (de) Herstellung von vakzinen unter der verwendung von hybrid-zellen
ES449890A1 (es) Procedimiento para el tratamiento de proteina de celula sim-ple.
AR016774A1 (es) Identificacion de lineas celulares humanas para la produccion de proteinas humanas por activacion genica endogena
DE69004964T2 (de) Zellenzuchtverfahren für die produktion von aktiviertem protein-c.